Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$461M |
| 2 |
American Tower
AMT
|
+$401M |
| 3 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$399M |
| 4 |
US Bancorp
USB
|
+$346M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$316M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$589M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$506M |
| 3 |
Lockheed Martin
LMT
|
+$418M |
| 4 |
RTN
Raytheon Company
RTN
|
+$373M |
| 5 |
Procter & Gamble
PG
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.78% |
| 2 | Healthcare | 12.43% |
| 3 | Financials | 11.93% |
| 4 | Consumer Discretionary | 9.96% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Caesarstone
CSTE
$72.3M
| $578K | ﹤0.01% |
48,741
| – | – |
|
2777
Organogenesis Holdings
ORGO
$305M
| $575K | ﹤0.01% |
149,480
+26,386
| +21% | +$95.1K |
|
|
CCRN
2778
DELISTED
Cross Country Healthcare
CCRN
| $572K | ﹤0.01% |
92,717
+2,393
| +3% | +$14.7K |
|
2779
First Bancorp
FNLC
$396M
| $572K | ﹤0.01% |
26,348
+63
| +0.2% | +$1.3K |
|
2780
Cadiz
CDZI
$251M
| $569K | ﹤0.01% |
55,957
+14,031
| +33% | +$157K |
|
2781
Lexicon Pharmaceuticals
LXRX
$1.03B
| $567K | ﹤0.01% |
283,894
+17,201
| +6% | +$33.7K |
|
2782
First Capital
FCAP
$212M
| $566K | ﹤0.01% |
8,142
+234
| +3% | +$13.7K |
|
2783
Alpha and Omega Semiconductor
AOSL
$950M
| $565K | ﹤0.01% |
51,877
+2,228
| +4% | +$22.8K |
|
2784
StoneCo
STNE
$2.77B
| $565K | ﹤0.01% |
+14,574
| New | +$425K |
|
2785
Farmers & Merchants Bancorp
FMAO
$459M
| $563K | ﹤0.01% |
26,466
| – | – |
|
|
CNBKA
2786
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $559K | ﹤0.01% |
7,187
| – | – |
|
2787
MediciNova
MNOV
$65.5M
| $557K | ﹤0.01% |
102,740
+3,306
| +3% | +$17.5K |
|
2788
Business First Bancshares
BFST
$1.04B
| $556K | ﹤0.01% |
36,170
+5,310
| +17% | +$71.8K |
|
|
CYBE
2789
DELISTED
Cyberoptics Corp
CYBE
| $556K | ﹤0.01% |
+17,243
| New | +$481K |
|
2790
Citi Trends
CTRN
$555M
| $555K | ﹤0.01% |
27,410
| – | – |
|
2791
MeiraGTx Holdings
MGTX
$1.09B
| $555K | ﹤0.01% |
44,256
+6,794
| +18% | +$94.7K |
|
2792
SmartFinancial
SMBK
$896M
| $555K | ﹤0.01% |
34,276
+2,780
| +9% | +$40.6K |
|
|
DSSI
2793
DELISTED
Diamond S Shipping Inc. Common Shares
DSSI
| $547K | ﹤0.01% |
68,392
+2,842
| +4% | +$30K |
|
2794
Fulcrum Therapeutics
FULC
$273M
| $546K | ﹤0.01% |
29,798
+3,029
| +11% | +$47.7K |
|
|
CHMA
2795
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $546K | ﹤0.01% |
101,341
+21,880
| +28% | +$120K |
|
2796
RBB Bancorp
RBB
$448M
| $544K | ﹤0.01% |
39,802
+1,587
| +4% | +$20.5K |
|
|
ISEE
2797
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $544K | ﹤0.01% |
+106,608
| New | +$444K |
|
2798
ACNB Corp
ACNB
$656M
| $542K | ﹤0.01% |
20,672
-998
| -5% | -$24.8K |
|
2799
Alpha Pro Tech
APT
$50.4M
| $542K | ﹤0.01% |
+30,571
| New | +$422K |
|
|
EBTC
2800
DELISTED
Enterprise Bancorp
EBTC
| $542K | ﹤0.01% |
22,745
+1,018
| +5% | +$23.6K |
|
Similar funds
Charles Schwab's Q2 2020 Portfolio in Review
As of Q2 2020, Charles Schwab held 3,435 positions worth $204B, up 20% from $170B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2020 filing shows 201 new, 1,862 increased, 1,124 reduced and 116 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M. The largest sale was Intel, an estimated $589M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2020 buy was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M.
- Charles Schwab added most to iShares Core S&P 500 ETF in Q2 2020, an estimated $461M increase.
- Charles Schwab's biggest Q2 2020 reduction was Intel, cutting an estimated $589M.
- Charles Schwab fully exited Raytheon Company in Q2 2020, selling an estimated $373M.
- Charles Schwab's ten largest holdings make up 17% of its $204B portfolio in Q2 2020.
- Charles Schwab opened 201 new positions and closed 116 in Q2 2020.
- Charles Schwab's portfolio value rose 20% quarter-over-quarter to $204B.
Based on Charles Schwab's 13F filing for Q2 2020, filed 14 Aug 2020.